ERBB2 and neoplasm: Pathological findings revealed metastatic adenocarcinoma, HER2 (3+), and gene testing verified the presence of HER2 amplification in axillary lymph nodes, prompting a systemic examination to look for the primary tumor, and abdominal computed tomography (CT) revealed a mass in the gastric body.